Trial intelligence / Profile preview

Ibandronic acid for hepatic osteodystrophy in liver cirrhosis

NCT02249741Phase 4Completed

Start
Aug 2012
Primary completion
Feb 2014
Countries
1
01

Overview

A Phase 4 trial of ibandronic acid in osteoporosis. Started Aug 2012; status: completed.

02

Drugs

ibandronic acid
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT02249741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02249741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call